TELA Latest News, Press Relases and Analysis

All

Press Releases

19 days ago - By: TELA Bio, Inc.

TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference

19 days ago - By: TELA Bio, Inc.

TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference

20 days ago - By: Benzinga - Mentions: LGN AES HON REG ...

Alphabet To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Tuesday

21 days ago - By: TELA Bio, Inc.

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

24 days ago - By: Benzinga

These Analysts Cut Their Forecasts On TELA Bio After Q3 Earnings

a month ago - By: TELA Bio, Inc.

TELA Bio to Announce Third Quarter 2025 Financial Results

21 days ago - By: TELA Bio, Inc.

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

25 days ago - By: Zacks Investment Research - Mentions: NTRB

TELA Bio, Inc. (TELA) Reports Q3 Loss, Misses Revenue Estimates

25 days ago - By: TELA Bio, Inc.

TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants

4 months ago - By: TELA Bio, Inc.

TELA Bio Reports Second Quarter 2025 Financial Results

4 months ago - By: TELA Bio, Inc.

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

25 days ago - By: TELA Bio, Inc.

TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants

25 days ago - By: TELA Bio, Inc.

TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility

25 days ago - By: TELA Bio, Inc.

TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility

a month ago - By: Zacks Investment Research - Mentions: HUMA

Humacyte, Inc. (HUMA) Reports Q3 Loss, Misses Revenue Estimates

a month ago - By: Zacks Investment Research - Mentions: CTKB

Cytek Biosciences, Inc. (CTKB) Reports Q3 Loss, Tops Revenue Estimates

5 months ago - By: TELA Bio, Inc.

TELA Bio to Announce Second Quarter 2025 Financial Results

6 months ago - By: TELA Bio, Inc.

TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

a month ago - By: TELA Bio, Inc.

TELA Bio to Announce Third Quarter 2025 Financial Results

a month ago - By: TELA Bio, Inc.

TELA Bio Appoints William Plovanic to Board of Directors

2 months ago - By: TELA Bio, Inc.

TELA Bio Announces Addition of Betty Jo Rocchio to Board of Directors and the Departure of Director Lisa Colleran

2 months ago - By: TELA Bio, Inc.

TELA Bio Announces Addition of Betty Jo Rocchio to Board of Directors and the Departure of Director Lisa Colleran

4 months ago - By: Zacks Investment Research - Mentions: ADCT

TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates

4 months ago - By: TELA Bio, Inc.

TELA Bio Reports Second Quarter 2025 Financial Results

4 months ago - By: TELA Bio, Inc.

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

4 months ago - By: Zacks Investment Research - Mentions: PRME

Prime Medicine, Inc. (PRME) Reports Q2 Loss, Lags Revenue Estimates

4 months ago - By: Zacks Investment Research - Mentions: GERN

Geron (GERN) Reports Q2 Loss, Tops Revenue Estimates

5 months ago - By: TELA Bio, Inc.

TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference

5 months ago - By: TELA Bio, Inc.

TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference

5 months ago - By: TELA Bio, Inc.

TELA Bio to Announce Second Quarter 2025 Financial Results

6 months ago - By: TELA Bio, Inc.

TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

6 months ago - By: TELA Bio, Inc.

TELA BIO INC (TELA) Stock News

TELA Latest News, Press Relases and Analysis

TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference

TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference

Alphabet To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Tuesday

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

These Analysts Cut Their Forecasts On TELA Bio After Q3 Earnings

TELA Bio to Announce Third Quarter 2025 Financial Results

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio, Inc. (TELA) Reports Q3 Loss, Misses Revenue Estimates

TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants

TELA Bio Reports Second Quarter 2025 Financial Results

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants

TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility

TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility

Humacyte, Inc. (HUMA) Reports Q3 Loss, Misses Revenue Estimates

Cytek Biosciences, Inc. (CTKB) Reports Q3 Loss, Tops Revenue Estimates

TELA Bio to Announce Second Quarter 2025 Financial Results

TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio to Announce Third Quarter 2025 Financial Results

TELA Bio Appoints William Plovanic to Board of Directors

TELA Bio Announces Addition of Betty Jo Rocchio to Board of Directors and the Departure of Director Lisa Colleran

TELA Bio Announces Addition of Betty Jo Rocchio to Board of Directors and the Departure of Director Lisa Colleran

TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates

TELA Bio Reports Second Quarter 2025 Financial Results

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Prime Medicine, Inc. (PRME) Reports Q2 Loss, Lags Revenue Estimates

Geron (GERN) Reports Q2 Loss, Tops Revenue Estimates

TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference

TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference

TELA Bio to Announce Second Quarter 2025 Financial Results

TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair